Transplantation of Human Embryonic Stem Cell–Derived Pericyte-Like Cells Transduced with Basic Fibroblast Growth Factor Promotes Angiogenic Recovery in Mice with Severe Chronic Hindlimb Ischemia
Journal of Cardiovascular Translational Research · 2024
DOI: 10.1007/s12265-024-10496-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Translational Research, 2024. Verfasst von Kenichiro Shimatani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Regenerative Medicine Applied Cell Therapy Research, Astellas Pharma Incorporated, 21 Miyukigaoka, Tsukuba-Shi, Ibaraki, 305-8585, Japa…. Hauptthemen laut MEDLINE: Fibroblast Growth Factor 2, Hindlimb, Neovascularization, Physiologic, Pericytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Critical limb ischemia (CLI) is a state of severe peripheral artery disease, with no effective treatment. Cell therapy has been investigated as a therapeutic tool for CLI, and pericytes are promising therapeutic candidates based on their angiogenic properties. We firstly generated highly proliferative and immunosuppressive pericyte-like cells from embryonic stem (ES) cells. In order to enhance the angiogenic potential, we transduced the basic fibroblast growth factor (bFGF) gene into the pericyte-like cells and found a significant enhancement of angiogenesis in a Matrigel plug assay. Furthermore, we evaluated the bFGF-expressing pericyte-like cells in the previously established chronic hindlimb ischemia model in which bone marrow-derived MSCs were not effective. As a result, bFGF-expressing pericyte-like cells significantly improved blood flow in both laser Doppler perfusion imaging (LDPI) and dynamic contrast-enhanced MRI (DCE-MRI). These findings suggest that bFGF-expressing pericyte-like cells differentiated from ES cells may be a therapeutic candidate for CLI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Regenerative Medicine Applied Cell Therapy Research, Astellas Pharma Incorporated, 21 Miyukigaoka, Tsukuba-Shi, Ibaraki, 305-8585, Japan. kenichiro.shimatani@astellas.com.
- Institute for Regenerative Medicine Applied Cell Therapy Research, Astellas Pharma Incorporated, 21 Miyukigaoka, Tsukuba-Shi, Ibaraki, 305-8585, Japan.
- Joint Research Chair On Design for Advanced Medical System, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka, 565-0871, Japan.
- Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
- Graduate School of Frontier Biosciences, Osaka University, 1-3 Yamadaoka, Suita, Osaka, 565-0871, Japan.
- Center for Information and Neural Networks (CiNet), National Institute of Information and Communications Technology (NICT) and Osaka University, 1-4 Yamadaoka, Suita, Osaka, 565-0871, Japan.
ORCID-Profile: Kenichiro Shimatani
Zitieren
APA
Shimatani, K., Sato, H., Mizukami, K., Saito, A., Sasai, M., Enmi, J. I., Watanabe, K., Kamohara, M., Yoshioka, Y., Miyagawa, S., & Sawa, Y. (2024). Transplantation of Human Embryonic Stem Cell–Derived Pericyte-Like Cells Transduced with Basic Fibroblast Growth Factor Promotes Angiogenic Recovery in Mice with Severe Chronic Hindlimb Ischemia. Journal of Cardiovascular Translational Research. https://doi.org/10.1007/s12265-024-10496-9
Vancouver
Shimatani K, Sato H, Mizukami K, Saito A, Sasai M, Enmi JI, et al. Transplantation of Human Embryonic Stem Cell–Derived Pericyte-Like Cells Transduced with Basic Fibroblast Growth Factor Promotes Angiogenic Recovery in Mice with Severe Chronic Hindlimb Ischemia. Journal of Cardiovascular Translational Research. 2024. doi:10.1007/s12265-024-10496-9
BibTeX
@article{Shimatani2024,
author = {Shimatani, Kenichiro and Sato, Hiromu and Mizukami, Kazuhiko and Saito, Atsuhiro and Sasai, Masao and Enmi, Jun-Ichiro and Watanabe, Kenichi and Kamohara, Masazumi and Yoshioka, Yoshichika and Miyagawa, Shigeru and Sawa, Yoshiki},
title = {Transplantation of Human Embryonic Stem Cell–Derived Pericyte-Like Cells Transduced with Basic Fibroblast Growth Factor Promotes Angiogenic Recovery in Mice with Severe Chronic Hindlimb Ischemia},
journal = {Journal of Cardiovascular Translational Research},
year = {2024},
doi = {10.1007/s12265-024-10496-9}
}
EUVIMED